UNDA 202
UNDA 202
Discontinued
DIN Number
02236595
Drug Class
Human
Market Date
Apr 6, 1998
Company
HC
seroyal international inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02236595
AIG Number0532403001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormDrops
,
Liquid
,
Tablet
,
Pellet
,
Granules
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification
ACTIVE INGREDIENTS (5)
CALCIUM FLUORIDEActive
Strength: 12 X
Monograph: CALCIUM FLUORIDE
COPPERActive
Strength: 12 X
Monograph: COPPER
GELSEMIUM SEMPERVIRENSActive
Strength: 4 X / XMK
Monograph: GELSEMIUM SEMPERVIRENS
GOLDActive
Strength: 12 X
Monograph: GOLD
SULFURActive
Strength: 6 X
Monograph: SULFUR